About
Research
Patient Care
Education
Community
Jun 10, 2024
‘Cutting the cable’ between CD8+ T and T regulatory cells enhances checkpoint immunotherapy
“Our latest research reveals that CD8+ T cells, activated by PD-1 blockade to target melanoma, also interact with T regulatory cells, which subsequently dampen the immune response against the tumor,” said corresponding author Francesco Marangoni, UC Irvine assistant professor of physiology & biophysics.
Jun 04, 2024
UCI Health cancer specialists share research at national forum
UCI Health cancer clinicians and scientists presented key findings and insights that will help advance cancer research and care at the 2024 annual meeting of the American Society of Clinical Oncology (ASCO), one of the world’s largest scientific gatherings in the field.
May 31, 2024
UCI Anti-Cancer Challenge awards $1 million for promising cancer research
The UCI Anti-Cancer Challenge has awarded $1 million raised in 2023 to fund a new round of transformative research projects at the UCI Health Chao Family Comprehensive Cancer Center and its pediatric cancer affiliate, Children’s Hospital of Orange County (CHOC).
Matt Miller Director, Communications and Public Relations mrmille2@uci.edu
Michelle Strombeck Manager, Communications and Public Relations 312-498-8208 mstrombe@hs.uci.edu
Stay Connected
Professor Christopher Barty, a UCI physicist, is developing a machine that can selectively image cancer in the body and also eliminate that cancer while minimizing damage to any surrounding tissue.
Miguel Villalona Calero was named deputy director of the University of California, Irvine Chao Family Comprehensive Cancer Center and division chief for hematology/oncology. He will start on July 8.
When the UCI Health Chao Family Comprehensive Cancer Center's second clinical hub opens its doors July 16, the spacious, state-of-the-art facility in Irvine will extend elite cancer care within reach of residents throughout Orange County and beyond.
Jun 21, 2024 | LAist
Massive AAPI Cancer Study
The first national long-term study about cancer among Asian Americans has been launched to investigate health disparities among ethnic groups and uncover risk factors. “For example, Vietnamese have historically had higher rates of cervical cancer,” said Sora Tanjasiri, a public health professor at UC Irvine. “Koreans have higher rates of liver cancer and stomach cancer. You have to look at the nuances.”
May 28, 2024
Time Is on Cancer Immunotherapy’s Side
A new study led by a multidisciplinary research team at the University of California (UC), Irvine, demonstrates that the circadian clock can be leveraged to enhance the efficacy of checkpoint inhibitor cancer therapy.